Clinical trial
Radiation Therapy Combined With Paclitaxel and Carboplatin in Treating Patients…
NCT00023673 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00023673 |
|---|---|
| Title | Radiation Therapy Combined With Paclitaxel and Carboplatin in Treating Patients With Stage III Non-Small Cell Lung Cancer |
| Official title | A Phase I/II Dose Intensification Study Using Three Dimensional Conformal Radiation Therapy And Concurrent Chemotherapy For Patients With Inoperable, Non-Small Cell Lung Cancer |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Radiation |
| Interventions | carboplatin, paclitaxel, three-dimensional conformal radiation therapy |
| Enrollment | 63 |
| Start date | Jul 1, 2001 |
| Primary completion | Jan 1, 2009 |
| Completion | Nov 1, 2013 |
| First posted | Apr 9, 2003 |
| Last update posted | Dec 22, 2017 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: